Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
Abstract MERS-CoV continues to cause human outbreaks, so far in 27 countries worldwide following the first registered epidemic in Saudi Arabia in 2012. In this study, we produced a nanovaccine based on virus-like particles (VLPs). VLPs are safe vaccine platforms as they lack any replication-competen...
Main Authors: | Mona O. Mohsen, Dominik Rothen, Ina Balke, Byron Martina, Vilija Zeltina, Varghese Inchakalody, Zahra Gharailoo, Gheyath Nasrallah, Said Dermime, Kaspars Tars, Monique Vogel, Andris Zeltins, Martin F. Bachmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00365-w |
Similar Items
-
Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
by: Ina Balke, et al.
Published: (2020-02-01) -
Expression and characterisation of the ryegrass mottle virus non-structural proteins
by: Baļķe Ina, et al.
Published: (2010-01-01) -
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate
by: Xuelan Liu, et al.
Published: (2021-04-01) -
Diversity of pili-specific bacteriophages: genome sequence of IncM plasmid-dependent RNA phage M
by: Rumnieks Janis, et al.
Published: (2012-11-01) -
Synthesis and Immunological Evaluation of Virus-Like Particle-Milbemycin A3/A4 Conjugates
by: Andris Zeltins, et al.
Published: (2017-09-01)